Newborn Screening Market Competitive Insights, Trends and Demand 2020 to 2027 | Emergen Research

The integrated newborn screening market is a growing industry that aims to detect diseases and disorders in newborns early on in their lives. This type of screening is typically done within the first few days of a baby's life and can help prevent long-term health problems or even death. The Global Newborn Screening Market is forecasted to reach USD 2.27 Billion by 2027, according to a new report by Emergen Research.

Newborn screening is a vital part of the healthcare system, and it has been implemented in many countries around the world. Integrated newborn screening is a relatively new concept that combines several different types of testing into one comprehensive screening process. This type of screening is designed to detect a wide range of diseases and disorders that may not be picked up by individual tests. The integrated newborn screening market includes testing for various genetic disorders, metabolic disorders, and other conditions that can be life-threatening if left untreated.

One of the primary drivers of the integrated newborn screening market is the increasing awareness of the importance of early detection and prevention of diseases. Healthcare providers are placing more emphasis on early screening and diagnosis to prevent long-term health problems and improve patient outcomes. In addition, advances in technology and genetic testing have made it possible to detect a wider range of disorders than ever before, driving the growth of the market.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/4

Despite the growth potential of the integrated newborn screening market, there are several restraints that may limit its growth. One of the primary restraints is the lack of infrastructure and resources in some developing countries. Many healthcare systems in developing countries lack the necessary resources to provide comprehensive screening services to all newborns. Additionally, there may be cultural or societal barriers that prevent some parents from consenting to screening.

There are several key growth factors that are expected to drive the growth of the integrated newborn screening market in the coming years. One of the primary growth factors is the increasing adoption of point-of-care testing (POCT) devices. These devices can be used in a variety of settings, including hospitals, clinics, and even at home, making screening more accessible to parents and healthcare providers. In addition, the growing prevalence of chronic diseases, such as diabetes and heart disease, is driving the need for early screening and prevention.

Government organizations around the world are recognizing the importance of newborn screening and are investing in this industry. In the United States, for example, the Centers for Disease Control and Prevention (CDC) recommends that all newborns be screened for 35 core conditions, and many states have additional screening requirements. According to the CDC, approximately 4 million newborns are screened each year in the United States, and over 12,000 babies are identified with a condition that requires further evaluation.

Major Companies and Competitive Landscape:
Bio-Rad Laboratories Inc., Agilent Technologies Inc., Trivitron Healthcare, Natus Medical Inc., PerkinElmer Inc., AB Sciex LLC, Covidien Plc, Masimo Corp., GE Healthcare, and Waters Corp., among others.

The key players in the newborn screening market are typically divided into two categories: diagnostics companies and laboratories. Diagnostics companies are primarily involved in developing and manufacturing screening kits, while laboratories perform the actual screening tests and provide diagnostic services.

Some of the major players in the diagnostics segment of the newborn screening market include PerkinElmer Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, and NeoGen Labs. These companies offer a range of products, including screening kits, instruments, and software solutions. PerkinElmer, for example, offers a comprehensive newborn screening platform that includes screening kits, software, and instrumentation. Bio-Rad Laboratories, on the other hand, specializes in developing tests for inherited diseases.

The competitive landscape for the newborn screening market is constantly evolving, with new players entering the market and established players expanding their product offerings. In addition to competition among companies, there is also competition among screening technologies. While traditional screening methods, such as tandem mass spectrometry, remain the gold standard for many conditions, new technologies, such as next-generation sequencing and digital microfluidics, are emerging as promising alternatives.

Overall, the newborn screening market is a highly competitive industry with numerous players competing for market share. With increasing emphasis on early screening and diagnosis of diseases in newborns, the market is expected to continue to grow and evolve in the coming years.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/4

Segmentation Insights for Cloud Computing Market Report:

Emergen Research has conducted a market segmentation of the global newborn screening market on the basis of technology, product, application, and region. The market is segmented into various technologies, including tandem mass spectrometry, pulse oximetry, enzyme-based assay, DNA assay, electrophoresis, and others. Tandem mass spectrometry is a widely used technology for newborn screening, and it is expected to dominate the market during the forecast period.

The product segment of the market is categorized into instruments, reagents, assay kits, and others. The increasing demand for reliable and efficient diagnostic tools has led to the growth of the instruments and reagents segments in the newborn screening market. Assay kits are also becoming increasingly popular for screening newborns for various diseases.

In terms of applications, the market is segmented into dry blood spot test, critical congenital heart disease (CCHD), hearing screen, and others. Dry blood spot testing is a widely used method for newborn screening, and it is expected to continue to dominate the market during the forecast period. The CCHD segment is also expected to witness significant growth due to the increasing incidence of heart diseases in newborns.

Geographically, the global newborn screening market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global newborn screening market due to the high adoption of advanced technologies, increasing healthcare expenditure, and favorable reimbursement policies. The Asia Pacific region is also expected to witness significant growth during the forecast period due to the increasing prevalence of genetic disorders, rising awareness regarding early diagnosis, and growing healthcare infrastructure.

Overall, the global newborn screening market is witnessing significant growth due to the increasing prevalence of genetic disorders and the growing demand for early diagnosis and treatment of diseases in newborns. The market is highly competitive, with numerous players competing for market share. With increasing emphasis on early screening and diagnosis of diseases in newborns, the market is expected to continue to grow and evolve in the coming years.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/new-born-screening-market

Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions.

This release was published on openPR.